Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ambalal Sarabhai Enterprises (ASE) is a historic Indian conglomerate with a significant legacy in the pharmaceutical and healthcare sectors. Founded by the Sarabhai family, the company was a pioneer in the Indian pharmaceutical industry, establishing landmark ventures such as Sarabhai Chemicals and Synbiotics. Today, the group operates through various subsidiaries and divisions, focusing on the manufacture and marketing of pharmaceutical formulations, bulk drugs, and veterinary products. Its healthcare portfolio is particularly noted for its historical contributions to antibiotics, vitamins, and antifungal treatments. ASE is publicly listed on the Bombay Stock Exchange and continues to leverage its industrial expertise in the Indian life sciences landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ambalal Sarabhai Enterprises Group.